Radiolabeled cetuximab: dose optimization for epidermal growth factor receptor imaging in a head-and-neck squamous cell carcinoma model.
about
Theranostic applications of antibodies in oncology.Systematic analysis of 18F-FDG PET and metabolism, proliferation and hypoxia markers for classification of head and neck tumorsRadiolabeled Cetuximab Conjugates for EGFR Targeted Cancer Diagnostics and TherapyExtracellular domain shedding influences specific tumor uptake and organ distribution of the EGFR PET tracer 89Zr-imgatuzumabDrug-based optical agents: infiltrating clinics at lower risk.Radionuclide imaging of drug delivery for patient selection in targeted therapy.Zirconium-89 labeled antibodies: a new tool for molecular imaging in cancer patients.Epidermal growth factor receptor imaging in human head and neck cancer xenografts.Applying near-infrared photoimmunotherapy to B-cell lymphoma: comparative evaluation with radioimmunotherapy in tumor xenografts.PET of EGFR with (64) Cu-cetuximab-F(ab')2 in mice with head and neck squamous cell carcinoma xenografts.Bevacizumab reduces tumor targeting of antiepidermal growth factor and anti-insulin-like growth factor 1 receptor antibodies.Harnessing Integrative Omics to Facilitate Molecular Imaging of the Human Epidermal Growth Factor Receptor Family for Precision Medicine.Performance evaluation of small-animal multipinhole μSPECT scanners for mouse imaging.
P2860
Q27693293-44A1087E-ECB7-4CC1-A72F-9B2F5FC63DFBQ35103263-B05A7907-D361-44F7-AF64-DBF716AD36A4Q37689802-3ED3313B-73E4-4E1F-BE15-934A4FD190CBQ37708758-F4FFD687-36EA-460D-9492-EA399C7BCB7EQ38010677-F7EE91FB-A2F3-4D79-996C-AE06C16462A5Q38176652-75E8420F-0A43-4E9A-BEE4-C8805B9E3D7EQ38225877-D68F7183-0210-4A13-B0C3-F93FA7341818Q38561772-341E2D39-CEB1-4E8E-9F04-FBC77CE264D6Q38696425-D62FE68A-72ED-4D56-9A66-6890D1963FE2Q38846349-61A33B3F-BCB0-48AA-B771-18CD5E6F1D6EQ39207594-94B1FC9E-5F07-4406-A9BD-7F17F1E010B3Q39389369-4F0D635A-6719-4F13-8596-C9C5BD4FBCD9Q46109699-A49A6736-E240-4C2D-BBF9-E6A85CD0A656
P2860
Radiolabeled cetuximab: dose optimization for epidermal growth factor receptor imaging in a head-and-neck squamous cell carcinoma model.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Radiolabeled cetuximab: dose o ...... squamous cell carcinoma model.
@en
Radiolabeled cetuximab: dose o ...... squamous cell carcinoma model.
@nl
type
label
Radiolabeled cetuximab: dose o ...... squamous cell carcinoma model.
@en
Radiolabeled cetuximab: dose o ...... squamous cell carcinoma model.
@nl
prefLabel
Radiolabeled cetuximab: dose o ...... squamous cell carcinoma model.
@en
Radiolabeled cetuximab: dose o ...... squamous cell carcinoma model.
@nl
P2093
P2860
P50
P356
P1476
Radiolabeled cetuximab: dose o ...... squamous cell carcinoma model.
@en
P2093
Bianca A W Hoeben
Janneke D M Molkenboer-Kuenen
Johannes H A M Kaanders
Wenny J M Peeters
Wim J G Oyen
P2860
P304
P356
10.1002/IJC.25727
P577
2010-12-01T00:00:00Z